DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Qin S, Bai Y, Lim HY. et al.
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.
J Clin Oncol 2013;
31 (28) 3501-3508
We do not assume any responsibility for the contents of the web pages of other providers.